Jodi Ann Cook
Independent DirectorDr. Jodi Ann Cook, Ph.D. is President, CEO, and Director of Skylark Bio, Inc. She is a Independent Chair at STRM.BIO INCORPORATED. She serves as an Independent Director of Fennec Pharmaceuticals Inc. since September 2019. Dr. Cook was Head of Gene Therapy Strategy at PTC Therapeutics, Inc. since August 2018 until 2020. Prior to joining PTC Therapeutics, she was one of the founding members and Chief Operating Officer of Agilis Biotherapeutics, a clinical stage AAV gene therapy company, from 2013 until its acquisition by PTC in 2018. Dr. Cook served as Vice President of Operations & Strategic Alliances at Agilis Biotherapeutics, LLC. Dr. Cook served as Chief Operating Officer at Agilis Biotherapeutics, LLC. Dr. Cook served as Vice President of Operations at Agilis Biotherapeutics, LLC since June 2014. Dr. Cook served as Vice President of Clinical Research / Professional Relations at InSound Medical, Inc. Dr. Cook has extensive experience in gene therapy development from initial research development through commercialization. Dr. Cook was an Assistant Professor at Arizona State University and Mayo Clinic, Rochester, MN. Dr. Cook earned a BA from Loyola University in Maryland, M.Aud. from University of South Carolina, and PhD from Arizona State University in Hearing Science. She completed a clinical fellowship at Johns Hopkins School of Medicine in Baltimore, MD.
Positions
- Company NameFennec Pharmaceuticals Inc.Stock CodeFENCPositionIndependent DirectorColleagues
- JSJeffrey S. HackmanCEO & Director
- KIKhalid IslamIndependent Chairman of the Board
- RCRobert C. AndradeChief Financial Officer
- PSPierre S. SayadChief Medical Officer
- TETerry EvansChief Commercial Officer
- CCChristiana CioffiChief Strategy Officer
- CAChris A. RallisIndependent Director
- MMMarco Maria BrugheraIndependent Director
